EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2019 0.0025
September 30, 2019 -0.4903
June 30, 2019 -0.7585
March 31, 2019 -0.4983
December 31, 2018 -0.7123
September 30, 2018 -0.4772
June 30, 2018 -0.3588
March 31, 2018 -0.3735
December 31, 2017 -0.2907
September 30, 2017 -0.3344
June 30, 2017 -0.3762
March 31, 2017 -0.3644
December 31, 2016 -0.3891
September 30, 2016 -0.5511
June 30, 2016 0.1072
March 31, 2016 -0.1466
December 31, 2015 -0.2495
September 30, 2015 -0.4855
June 30, 2015 -0.3569
March 31, 2015 -0.5551
December 31, 2014 -0.0237
September 30, 2014 -0.5287
June 30, 2014 -0.1823
March 31, 2014 -0.4944
December 31, 2013 -0.6722
Date Value
September 30, 2013 -0.5281
June 30, 2013 -0.595
March 31, 2013 -0.9027
December 31, 2012 -1.970
September 30, 2012 -0.6649
June 30, 2012 0.5849
March 31, 2012 -0.0001
December 31, 2011 -2.252
September 30, 2011 0.0001
June 30, 2011 -0.7648
March 31, 2011 4.782
September 30, 2010 -1.275
June 30, 2010 -0.2898
March 31, 2010 -0.7349
December 31, 2009 -1.908
September 30, 2009 -2.389
June 30, 2009 -1.964
March 31, 2009 -0.5935
December 31, 2008 -1.701
September 30, 2008 -2.853
June 30, 2008 -2.730
March 31, 2008 -2.958
December 31, 2007 -3.300
September 30, 2007 -2.400
June 30, 2007 -2.048

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
InflaRx NV -0.1052
BioNTech SE -3.799
Immatics NV -0.5316
Arrowhead Pharmaceuticals, Inc. -1.355
Oncolytics Biotech, Inc. -0.0788